Codiak BioSciences Inc. (CDAK)

NASDAQ: CDAK · Real-Time Price · USD

0.06

0.00 (5.26%)

At close: Apr 04, 2023, 8:00 PM

Codiak BioSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-37.16M	-91.67M	-77.96M	-44.54M
Depreciation & Amortization	6.42M	5.55M	2.77M	1.73M
Stock-Based Compensation	10.14M	7.08M	7.25M	5.36M
Other Working Capital	-20.87M	13.05M	65.43M	-392K
Other Non-Cash Items	470K	3.05M	391K	7.81M
Deferred Income Tax	-33.24M	-40K	-1.05M	n/a
Change in Working Capital	-20.78M	12.67M	66.9M	-928K
Operating Cash Flow	-74.14M	-63.36M	-1.7M	-30.57M
Capital Expenditures	-3.25M	-21.05M	-10.48M	-8.32M
Cash Acquisitions	n/a	n/a	n/a	6.5M
Purchase of Investments	n/a	n/a	-130.69M	-97.23M
Sales Maturities Of Investments	n/a	73.06M	129.5M	27M
Other Investing Acitivies	n/a	n/a	n/a	-6.5M
Investing Cash Flow	-3.25M	52.01M	-11.67M	-78.54M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	65.41M	89.58M	9.76M	-58K
Financial Cash Flow	65.41M	89.58M	9.76M	-58K
Net Cash Flow	-11.98M	78.23M	-3.61M	-109.17M
Free Cash Flow	-77.39M	-84.41M	-12.18M	-38.89M